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Poster Session II S327hardship, and physical location prevent adequate caregiver
education.
In the spring of 2008, UCSD BMT nurses and transplant coordi-
nators developed an extensive BMT education program for alloge-
neic BMT patients and their caregivers. Curriculum of the
program includes infection prevention, proper medication adminis-
tration and ensuring the safe transition for the patient from inpatient
to outpatient care. Primary objectives in creating this education pro-
gram were decreased anxiety and distress, infection prevention, and
increased medication compliance.
The Program’s education strategies include:
A customized BMT patient reference manual, provided to the
patient and caregiver during the first patient visit. (The manual is
available in both English and Spanish)
One-on-one education sessions for the patient with the RN/trans-
plant coordinator
The BMT caregiver class. The scheduled caregiver class, which
brings several BMT caregivers together, provides education, mutual
support and the opportunity to develop coping mechanisms. The
class provides a special focus on the discharge and home experience
of the BMT patient.
Patient teaching prior to discharge from the hospital.
Preliminary results of caregiver class based on post class surveys
indicate that patients had less anxiety, emotional distress, and im-
proved feelings of coping after attending the caregiver class. These
results indicate that further support is needed for caregivers of allo-
geneic transplant recipients. The BMT nurses/transplant coordina-
tors will continue to refine the allogeneic education program, based
on measured outcomes including post class survey and distress
management tool.466
CATHETER-ASSOCIATED BLOOD STREAM INFECTION (CA-BSI) REDUC-
TION PROJECT ON 2 BMT INPATIENT UNITS
Stenstrup, E., Hagerman, A., Mielke, C. University of MinnesotaMedical
Center, Minneapolis, MN
Purpose: This nursing-centered project was created to reduce the
number of CA-BSIs on both the Adult and Pediatric BMT inpatient
units.
Background: A central venous catheter (CVC) is paramount for
the care of the BMT patient. At our facility, we perform autolo-
gous and allogeneic transplants. These types of patients require
intense, acute nursing care, with some needing critical nursing
care. The CVC allows nursing staff to administer medications
and blood products, draw blood specimens, and monitor patient
hemodymanics. Literature shows there is an increase in CA-BSI
risk with multiple entries into the lines connected to the CVC or
the CVC itself (Crnich & Maki, 2005). CA-BSIs contribute sig-
nificantly to morbidity, mortality, and cost (O’Grady, 2002). In
an effort to decrease the burden of CA-BSIs, our facility em-
barked upon a nursing-centered PI project to reduce CA-BSIs.
Interventions:We began our project in early 2008. We have contin-
ued into 2009 in order to monitor the outcomes of the interventions.
Our implementation strategies in 2008 were three-fold: re-educate
all staff, require hands on CVC competencies, and employ the Infec-
tion Prevention Department. Education consisted of review of liter-
ature, rates, CVC policy review, and correct technique when
working with a CVC. During staff’s yearly competencies, reviews
and updates are given related to the project. They must be checked
off on correct CVC technique. Monthly CA-BSI rates are shared
with staff and quarterly rates shared with the BMT Quality Commit-
tee.
Evaluation: We noted a 50% decrease in our CA-BSI rates on both
units with the initial rollout of this project and during 2008. We have
seen a small rise in our rates in the first half of 2009. We evaluate our
interventions on a monthly basis. We consider patient populations,
staffing levels, the infecting organism, and other relevant factors.
We have made changes to the interventions first defined for this pro-
ject. We will continue to evaluate our rates based on those changes.
Discussion: As with any project, sustaining change is key. We
have experienced an overall reduction in our CA-BSI rates. Our
goal is to reduce our rates to below our benchmark and sustain
this rate for one year. Inviting nursing staff to the initial projectdiscussion has proven to be an integral piece to the design of
this project. Staff has helped us identify and address barriers to
change and helped us create strategies to support practice
change.467
EVALUATION AND TREATMENT OF DIARRHEA IN THE BLOOD AND MAR-
ROW TRANSPLANT RECIPIENT: DEVELOPMENT OF AN EVIDENCE-BASED
PLAN OF CARE
Gilmore, D.N. OSU James Cancer Hospital, Columbus, OH
Diarrhea is a common symptom experienced by both autolo-
gous and allogeneic blood and marrow transplant recipients that
can present at any time over the course of transplant. Diarrhea af-
fects the patient’s comfort, can increase length of hospital stay and
cost of care, and can be debilitating and life-threatening. The
cause of diarrhea in the transplant patient has several possible eti-
ologies and can be multi-factorial. Causes include infection (in-
cluding Clostridium difficile) and graft versus host disease and
diarrhea can be chemotherapy or treatment related. In an attempt
to standardize evaluation and treatment of diarrhea in the trans-
plant patient, a plan of care was developed to guide care of the
transplant patient who presents with diarrhea. A review of the lit-
erature was completed. Input was obtained from institutional phy-
sicians from the blood and marrow transplant, infectious disease,
and gastroenterology departments and from the pharmacy depart-
ment. An evidence-based plan of care was developed using the
gathered information. The plan of care includes a total of three in-
terwoven algorithms. The first includes initial evaluation and
treatment of diarrhea, focused on the treatment of chemother-
apy/treatment related diarrhea. The second is an algorithm fo-
cused on the treatment of Clostridium difficile diarrhea. The
third is an algorithm focused on the treatment of diarrhea caused
by graft versus host disease. The plan of care is multidisciplinary
and includes nursing, medical, and pharmaceutical interventions.
The complete plan of care is now available on the institutional in-
tranet as part of the blood and marrow transplant program policies
and procedures. It is used for reference by the blood and marrow
transplant program nurse practitioners, physicians, nurses and
other staff of the institution. Implementation of this plan of care
has helped to standardize care of the transplant patient with diar-
rhea. Additionally, Clostridium difficile infection rates on the
blood and marrow transplant unit have dramatically decreased in
part due to the implementation of faster isolation and enhanced
precautions in care of the patient with diarrhea as suggested by
the plan of care.468
UM,WHAT’S YOUR NAME AGAIN? IMPLEMENTING A BEDSIDE CHECK TO
DECREASE INCIDENCE OF PATIENT MISIDENTIFICATION-RELATED
CHEMOTHERAPY ERRORS
Spruill, A., Eron, B.W., Coghill, A., Farmer, A., Talbert, G. University of
North Carolina Health Care, Chapel Hill, NC
Patient harm due to incorrect administration of chemotherapy in
our Bone Marrow Transplant Unit (BMT) was identified as a pre-
ventable risk. According to the Institute of Safe Medication Practice,
high alert medications, such as chemotherapeutic agents, can lead to
significant patient harm, if used in error. After attending the Agency
for Healthcare Research and Quality TeamSTEPPS training and
peer discussion, BMT nursing staff implemented a practice change
intended to prevent patient misidentification medication errors –
a bedside check of chemotherapy. Per institutional policy, all
chemotherapy must be independently double checked by two
chemotherapy-competent nurses prior to administration. This veri-
fication does not include a bedside check. We defined a bedside
check as two chemotherapy-competent nurses comparing/verifying
the patient’s name and medical record number against the patient’s
identification armband and the same identifiers on the chemotherapy
product label at bedside.
A data collection tool that captured compliance with the bedside
check was designed. Data collection occurred November 1, 2008
to February 1, 2009. Briefing, which included scheduled
